AccessAfrica 2

AccessAfrica 2 is a Horizon Europe project (2023-2026) that aims to enhance ethical review and regulatory capacity for clinical trials in two Sub-Saharan African (SSA) countries. The project specifically focuses on the review and oversight of reported adverse events during clinical trials, improving the efficiencies of the National Ethics Committees (NECs) and National Regulatory Authorities (NRAs), and equipping them with the skills and knowledge necessary for improved operations during outbreaks and epidemics. The project involves collaboration with five partners from universities and research institutions, with the University of Oslo serving as the coordinating institution. Additionally, AccessAfrica 2 has received funding from the Global Health EDCTP3.